Japan IVD Centralized Diagnostics Market, Key Company Profiles, Market Dynamics And Recent Developments - Forecast To 2030
Dublin, Aug. 31, 2026 (GLOBE NEWSWIRE) -- The "Japan IVD Centralized Diagnostics Market, Key Company Profiles, Market Dynamics and Recent Developments - Forecast to 2030" has been added to ResearchAndMarkets.com's offering.
Japan IVD Centralized Diagnostics Market to Surpass US$2.20 Billion by 2030
Japan's in vitro diagnostics (IVD) centralized diagnostics market is projected to increase from US$1.95 billion in 2025 to more than US$2.20 billion by 2030. Market growth is being supported by universal healthcare coverage, an ageing population, expanding chronic disease prevalence, preventive screening programs and continued investment in advanced clinical laboratory infrastructure.
Centralized diagnostic laboratories remain fundamental to Japan's healthcare system, accounting for a substantial share of testing conducted across major hospitals, commercial laboratories and reference laboratories. These facilities support high-volume and complex diagnostic assays through automated platforms that improve standardization, throughput, precision and operating efficiency. Growing demand for early disease detection, precision medicine and advanced biomarker testing is expected to reinforce their strategic importance through 2030.
Immunoassay and Clinical Chemistry Lead Market Demand
Immunoassay and clinical chemistry collectively represented approximately 70% of the Japan IVD centralized diagnostics market in 2025. Immunoassay is the largest segment, driven by increasing demand for oncology, cardiac, infectious disease, endocrine, autoimmune and neurodegenerative disease biomarkers. Adoption of high-throughput chemiluminescence immunoassay systems and fully automated platforms continues to improve laboratory productivity and analytical performance.
Abbott, Fujirebio and Roche hold prominent positions in Japan's immunoassay market through comprehensive assay menus and established automated platforms. Abbott's ARCHITECT and Alinity systems, Fujirebio's high-value biomarker portfolio and Roche's cobas platforms support testing across oncology, cardiology, endocrinology, infectious diseases and other major clinical applications.
Clinical chemistry is the second-largest segment, supported by routine health examinations, preventive care and chronic disease management. High testing volumes are associated with diabetes, cardiovascular disease, kidney disorders, liver disease and metabolic conditions. Roche, FUJIFILM Wako, Minaris Medical, Sekisui Medical and ARKRAY maintain strong positions through their clinical chemistry analyzers, reagents and laboratory solutions.
Additional Market Segments
Hematology continues to generate stable demand through complete blood count testing, anemia assessment, infection monitoring and hematological malignancy detection. Sysmex leads Japan's hematology market, followed by Beckman Coulter and Siemens Healthineers, supported by extensive installations across hospitals and centralized laboratories.
Microbiology remains strategically important as healthcare providers strengthen pathogen identification, antimicrobial resistance surveillance and hospital infection control. bioMerieux maintains a leading position through blood culture, microbial identification and antimicrobial susceptibility testing solutions. Becton Dickinson and Beckman Coulter also support microbiology testing and laboratory workflow automation.
Japan's coagulation diagnostics segment is expected to record steady growth as cardiovascular disease, stroke, venous thromboembolism and bleeding disorders become more prevalent among older patients. Sysmex and Sekisui Medical hold significant market positions through coagulation analyzers, reagents and quality-control portfolios.
Recent Developments in Japan's Centralized Diagnostics Industry
- Fujirebio and Sysmex collaboration: In February 2026, Fujirebio and Sysmex entered a strategic sales collaboration for dementia diagnostics. Sysmex became the exclusive distributor of Fujirebio's fully automated LUMIPULSE immunoassay systems and dementia-related assay reagents in agreed markets. The collaboration combines Fujirebio's biomarker expertise with Sysmex's sales and service network, supporting wider adoption of automated blood-based dementia testing. Roche mass spectrometry expansion: In December 2025, Roche announced CE Mark approval for a mass spectrometry reagent pack for antibiotic drug monitoring. The cobas Mass Spec solution and Ionify reagent portfolio cover therapeutic drug monitoring, immunosuppressants, antibiotics, steroid hormones and vitamin D metabolites. The platform is available in Japan and other selected markets, enabling laboratories to transition toward more automated and standardized mass spectrometry workflows. Sysmex Mid-Term Management Plan: Sysmex's 2025-2028 strategy focuses on strengthening hematology, hemostasis, immunochemistry and laboratory automation while increasing investment in digital transformation and artificial intelligence-enabled diagnostics. The plan emphasizes integrated analyzers, automation systems and digital technologies designed to improve productivity, workflow efficiency and clinical decision-making.
Competitive Landscape
The Japan IVD centralized diagnostics market is highly consolidated and technologically competitive. Major international companies include Roche, Abbott, Siemens Healthineers, Beckman Coulter, bioMerieux, Becton Dickinson, Bio-Rad, Thermo Fisher Scientific, Werfen, Grifols and Immucor. Leading domestic and Japan-based participants include Sysmex, Fujirebio, Fujifilm, FUJIFILM Wako, HORIBA, Eiken Chemical, Sekisui Medical, ARKRAY, Minaris Medical, Denka, Tosoh, JEOL, Hitachi, Nihon Kohden and LSI Medience.
Competition increasingly centers on laboratory automation, expanded assay menus, artificial intelligence, digital connectivity, integrated workflow systems and advanced biomarkers. Companies with broad reagent portfolios, established analyzer installations and nationwide service capabilities are positioned to benefit from sustained demand across hospitals and independent diagnostic laboratories.
Report Scope
The report, "Japan IVD Centralized Diagnostics Market by Segment, Key Company Profiles, Market Dynamics and Recent Developments-Forecast to 2030," provides market size, share and forecast analysis from 2021 to 2030. It examines clinical chemistry, immunoassay, coagulation, urinalysis, hematology, flow cytometry, immunohematology and microbiology.
- Clinical chemistry instruments and reagents Immunoassay instruments, blood screening and reagents Coagulation instruments, services and testing categories Urinalysis instruments, qualitative testing and sediment analysis Hematology instruments, complete blood count testing and cell imaging analysis Flow cytometry Immunohematology, including blood grouping, antibody screening and antigen typing Microbiology, including automated identification, antimicrobial susceptibility testing and blood culture
The analysis also reviews company market shares, competitive strategies, recent industry developments and the principal factors influencing Japan's centralized diagnostics market. Long-term expansion is expected to remain stable as laboratories modernize their infrastructure and adopt high-throughput, data-driven diagnostic systems to address the country's changing healthcare requirements.
Key Topics Covered:
1. Executive Summary
2. Research Methodology
2.1 Research Design
2.2 Research Approach
2.3 Data Collection Methods
2.4 Market Assumptions
3. Japan IVD Centralized Diagnostics Market and Forecast (2021-2030)
3.1 By Segment - Japan IVD Centralized Diagnostics Market Share & Forecast
3.2 By Company - Japan IVD Centralized Diagnostics Market Share & Forecast
4. Japan - Clinical Chemistry Market & Forecast (2021-2030)
4.1 By Company - Japan Clinical Chemistry Market Revenue & Forecast
4.2 Japan - Clinical Chemistry (CC) Instruments Market & Forecast
4.3 By Company - Japan Clinical Chemistry Instruments Market Revenue & Forecast
4.3.1 Japan - CC Instruments Market & Forecast
4.3.2 By Company - Japan CC Instruments Market Revenue & Forecast
4.3.3 Japan - CCIA Combo systems Market & Forecast
4.3.4 By Company - Japan CCIA Combo systems Market Revenue & Forecast
4.4 Japan - Clinical Chemistry (CC) Reagents Market & Forecast
4.5 By Company - Japan Clinical Chemistry Reagents Market Revenue & Forecast
4.5.1 Japan Clinical Chemistry Reagents - Routine Testing Market & Forecast
4.5.2 By Company - Japan CC Routine Testing Market Revenue & Forecast
4.5.3 Japan Clinical Chemistry Reagents - Drugs of Abuse Testing Market & Forecast
4.5.4 By Company - Japan CC Drugs of Abuse Testing Market Revenue & Forecast
4.5.5 Japan Clinical Chemistry Reagents - Therapeutic Drug Monitoring Market & Forecast
4.5.6 By Company - Japan CC Therapeutic Drug Monitoring Market Revenue & Forecast
4.5.7 Japan Clinical Chemistry Reagents - HbA1c Testing Market & Forecast
4.5.8 By Company - Japan CC HbA1c Testing Market Revenue & Forecast
4.5.9 Japan Clinical Chemistry Reagents - Specific Proteins Testing Market & Forecast
4.5.10 By Company - Japan CC Specific Proteins Testing Market Revenue & Forecast
5. Japan - Immunoassay Market & Forecast (2021-2030)
5.1 By Company - Japan Immunoassay Market Revenue & Forecast
5.2 Japan - Immunoassay Instruments Market & Forecast
5.3 By Company - Japan Immunoassay Instruments Market Revenue & Forecast
5.4 Japan - Immunoassay Blood Screening Market & Forecast
5.5 By Company - Japan Immunoassay Blood Screening Market Revenue & Forecast
5.6 Japan - Immunoassay Reagents Market & Forecast
5.7 By Company - Japan Immunoassay Reagents Market Revenue & Forecast
5.7.1 Japan Immunoassay Reagents - Thyroid Testing Market & Forecast
5.7.2 By Company - Japan Immunoassay Thyroid Testing Market Revenue & Forecast
5.7.3 Japan Immunoassay Reagents - Anemia Testing Market & Forecast
5.7.4 By Company - Japan Immunoassay Anemia Testing Market Revenue & Forecast
5.7.5 Japan Immunoassay Reagents - Hormones Testing Market & Forecast
5.7.6 By Company - Japan Immunoassay Hormones Testing Market Revenue & Forecast
5.7.7 Japan Immunoassay Reagents - Oncology Testing Market & Forecast
5.7.8 By Company - Japan Immunoassay Oncology Testing Market Revenue & Forecast
5.7.9 Japan Immunoassay Reagents - Infectious Diseases Testing Market & Forecast
5.7.10 By Company - Japan Immunoassay Infectious Diseases Testing Market Revenue & Forecast
5.7.11 Japan Immunoassay Reagents - Fertility/Pregnancy Testing Market & Forecast
5.7.12 By Company - Japan Immunoassay Fertility/Pregnancy Testing Market Revenue & Forecast
5.7.13 Japan Immunoassay Reagents - Cardiac Market & Forecast
5.7.14 By Company - Japan Immunoassay Cardiac Market Revenue & Forecast
5.7.15 Japan Immunoassay Reagents - Critical Care Market & Forecast
5.7.16 By Company - Japan Immunoassay Critical Care Market Revenue & Forecast
5.7.17 Japan Immunoassay Reagents - Bone Health Market & Forecast
5.7.18 By Company - Japan Immunoassay Bone Health Market Revenue & Forecast
5.7.19 Japan Immunoassay Reagents - Autoimmune Disease Market & Forecast
5.7.20 By Company - Japan Immunoassay Autoimmune Disease Market Revenue & Forecast
5.7.21 Japan Immunoassay Reagents - Sars-Cov2 Market & Forecast
5.7.22 By Company - Japan Immunoassay Sars-Cov2 Market Revenue & Forecast
5.7.23 Japan Immunoassay Reagents - Allergy Market & Forecast
5.7.24 By Company - Japan Immunoassay Allergy Market Revenue & Forecast
5.7.25 Japan Immunoassay Reagents - Immunosuppressants Market & Forecast
5.7.26 By Company - Japan Immunoassay Immunosuppressants Market Revenue & Forecast
5.7.27 Japan Immunoassay Reagents - Neurology Market & Forecast
5.7.28 By Company - Japan Immunoassay Neurology Market Revenue & Forecast
6. Japan - Coagulation Market & Forecast (2021-2030)
6.1 By Company - Japan Coagulation Market Revenue & Forecast
6.1 Japan - Coagulation Instruments & Service Market & Forecast
6.2 By Company - Japan Coagulation Instruments & Service Market Revenue & Forecast
6.3 Japan - Coagulation Traditional Tests Market & Forecast
6.4 By Company - Japan Coagulation Traditional Tests Market Revenue & Forecast
6.5 Japan - Coagulation Other Tests Market & Forecast
6.6 By Company - Japan Coagulation Other Tests Market Revenue & Forecast
7. Japan - Urinalysis Market & Forecast (2021-2030)
7.1 By Company - Japan Urinalysis Market Revenue & Forecast
7.2 Japan - Urinalysis Instruments & Service Market & Forecast
7.3 By Company - Japan Urinalysis Instruments & Service Market Revenue & Forecast
7.4 Japan - Urinalysis Qualitative Market & Forecast
7.5 By Company - Japan Urinalysis Qualitative Market Revenue & Forecast
7.6 Japan - Urinalysis Sedimentation Tests Market & Forecast
7.7 By Company - Japan Urinalysis Sedimentation Tests Market Revenue & Forecast
8. Japan - Hematology Market & Forecast (2021-2030)
8.1 By Company - Japan Hematology Market Revenue & Forecast
8.2 Japan - Hematology Instruments & Service Market & Forecast
8.3 By Company - Japan Hematology Instruments & Service Market Revenue & Forecast
8.4 Japan - Hematology Blood Cell Count (CBC) Market & Forecast
8.5 By Company - Japan Hematology Blood Cell Count (CBC) Market Revenue & Forecast
8.6 Japan - Hematology Cell Imaging Analysis Market & Forecast
8.7 By Company - Japan Hematology Cell Imaging Analysis Market Revenue & Forecast
9. Japan - Flow Cytometry Market & Forecast (2021-2030)
9.1 By Company - Japan Flow Cytometry Market Revenue & Forecast
10. Japan - Immunohematology Market & Forecast (2021-2030)
10.1 By Company - Japan Immunohematology Market Revenue & Forecast
10.2 Japan - Immunohematology Blood Grouping & Typing Market & Forecast
10.3 By Company - Japan Immunohematology Blood Grouping & Typing Market Revenue & Forecast
10.4 Japan - Immunohematology Antibody Screening and Identification Market & Forecast
10.5 By Company - Japan Immunohematology Antibody Screening and Identification Market Revenue & Forecast
10.6 Japan - Immunohematology Antigen Typing Market & Forecast
10.7 By Company - Japan Immunohematology Antigen Typing Market Revenue & Forecast
11. Japan - Microbiology Market & Forecast (2021-2030)
11.1 By Company - Japan Microbiology Market Revenue & Forecast
11.2 Japan - Microbiology Automated ID/ AST Market & Forecast
11.3 By Company - Japan Microbiology Automated ID/ AST Market Revenue & Forecast
11.4 Japan - Microbiology Automated Blood Culture Market & Forecast
11.5 By Company - Japan Microbiology Automated Blood Culture Market Revenue & Forecast
11.6 Japan - Microbiology Manual ID/ AST + Culture Market & Forecast
11.7 By Company - Japan Microbiology Manual ID/ AST + Culture Market Revenue & Forecast
12. Japan IVD Centralized Diagnostics Market - Recent Developments
Companies Featured
- Roche Abbott Sysmex Fujirebio Siemens Sekisui Ortho Clinical Diagnostics Denka Arkray bioMerieux Danaher - Beckman Coulter Tosoh Fujifilm - Wako Fujifilm EIKEN CHEMICAL Minaris Shino-Test LSI Medience Canon - Canon JEOL Hitachi Bio-Rad Kanto Nittobo Kainos Nipro Kyokuto Thermo Fisher Scientific Thermo Fisher Scientific (Phadia) Thermo Fisher Scientific - Oxoid MBL Werfen Sanwa Horiba ABX - Horiba Nihon Kohden Becton Dickinson Grifols Immucor Nissui
For more information about this report visit
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept any
responsibility or liability for the accuracy, content, images, videos,
licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright issues
related to this article, kindly contact the provider above.
Comments
No comment